Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. (Record no. 28124859)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02044 a2200601 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517202940.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201907s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1538-8514 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1535-7163.MCT-17-0758 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Floc'h, Nicolas |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20190708 |
| 245 00 - TITLE STATEMENT | |
| Title | Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Molecular cancer therapeutics |
| Date of publication, distribution, etc. | 05 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 885-896 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Acrylamides |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aniline Compounds |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Animals |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | COS Cells |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cell Line, Tumor |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Chlorocebus aethiops |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | ErbB Receptors |
| General subdivision | antagonists & inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Exons |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mice, SCID |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Mutation |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Piperazines |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Protein Kinase Inhibitors |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Xenograft Model Antitumor Assays |
| General subdivision | methods |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Martin, Matthew J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Riess, Jonathan W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Orme, Jonathan P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Staniszewska, Anna D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ménard, Ludovic |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cuomo, Maria Emanuela |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Neill, Daniel J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ward, Richard A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Finlay, M Raymond V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | McKerrecher, Darren |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cheng, Mingshan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vang, Daniel P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Burich, Rebekah A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Keck, James G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gandara, David R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mack, Philip C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cross, Darren A E |
| 773 0# - HOST ITEM ENTRY | |
| Title | Molecular cancer therapeutics |
| Related parts | vol. 17 |
| -- | no. 5 |
| -- | p. 885-896 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1535-7163.MCT-17-0758">https://doi.org/10.1158/1535-7163.MCT-17-0758</a> |
| Public note | Available from publisher's website |
No items available.